Skip to main content

Advertisement

Table 2 Body mass index (BMI) and outcomes in diabetics and non-diabetics

From: Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61

  BMI < 25 BMI 25–29.9 BMI > 30 p value
MACE (1 year)
 Diabetics 21/91 (23.1%) 16/178 (9.0%) 16/135 (14.1%) 0.001
 Non diabetics 36/550 (6.6%) 44/744 (5.9%) 15/306 (4.9%) 0.621
Death (1 year)
 Diabetics 13/91 (14.3%) 9/178 (5.1%) 9/135 (6.7%) 0.023
 Non-diabetics 21/550 (3.8%) 17/744 (2.3%) 4/306 (1.3%) 0.065
Revascularization (1 year)
 Diabetics 13/91 (14.3%) 11/178 (6.2%) 7/135 (5.2%) 0.025
 Non-diabetics 26/550 (4.7%) 53/744 (7.1%) 15/306 (4.9%) 0.14
Stroke (1 year)
 Diabetics 1/91 (1.1%) 5/178 (2.8%) 3/135 (2.2%) 0.667
 Non-diabetics 5/550 (0.9%) 5/744 (0.7%) 3/306 (1.0%) 0.838